STING1 and neoplasm: Preliminary results showed that a newly developed STING agonist (JNJ‐67544412) could bind to all major alleles of human STING(hSTING), resulting in increased levels of pro‐inflammatory factors in the nuclear plasma of tumor‐bearing mice, increased numbers of CD8+ T cells, and accelerated tumor cell apoptosis.16